Literature DB >> 19459037

The effectiveness of family history questionnaires in cancer genetic counseling.

Susan Randall Armel1, Jeanna McCuaig, Amy Finch, Rochelle Demsky, Tony Panzarella, Joan Murphy, Barry Rosen.   

Abstract

The number of individuals receiving genetic counseling for hereditary breast and ovarian cancer syndrome has steadily risen. To triage patients for genetic counseling and to help reduce the amount of time needed by a genetic counselor in direct patient contact, many clinics have implemented the use of family history questionnaires. Although such questionnaires are widely used, scant literature exists evaluating their effectiveness. This article explores the extent to which family history questionnaires are being used in Ontario and addresses the utility of such questionnaires in one familial cancer clinic. By comparing the pedigrees created from questionnaires to those updated during genetic counseling, the accuracy and effectiveness of the questionnaires was explored. Of 121 families recruited into the study, 12% acquired changes to their pedigree that led to a revised probability estimate for having a BRCA1 or BRCA2 mutation and 5% acquired changes that altered their eligibility for genetic testing. No statistically significant difference existed between the eligibility for genetic testing prior to and post counseling. This suggests that family history questionnaires can be effective at obtaining a family history and accurately assessing eligibility for genetic testing. Based on the variables that were significantly associated with a change in probability estimate, we further present recommendations for improving the clarity of such questionnaires and therefore the ease of use by patients.

Entities:  

Mesh:

Year:  2009        PMID: 19459037     DOI: 10.1007/s10897-009-9228-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  16 in total

1.  The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Authors:  J M Satagopan; K Offit; W Foulkes; M E Robson; S Wacholder; C M Eng; S E Karp; C B Begg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

2.  Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

Authors:  Harvey A Risch; John R McLaughlin; David E C Cole; Barry Rosen; Linda Bradley; Isabel Fan; James Tang; Song Li; Shiyu Zhang; Patricia A Shaw; Steven A Narod
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

3.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

4.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

5.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Authors:  Donald A Berry; Edwin S Iversen; Daniel F Gudbjartsson; Elaine H Hiller; Judy E Garber; Beth N Peshkin; Caryn Lerman; Patrice Watson; Henry T Lynch; Susan G Hilsenbeck; Wendy S Rubinstein; Kevin S Hughes; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

6.  Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

Authors:  H A Risch; J R McLaughlin; D E Cole; B Rosen; L Bradley; E Kwan; E Jack; D J Vesprini; G Kuperstein; J L Abrahamson; I Fan; B Wong; S A Narod
Journal:  Am J Hum Genet       Date:  2001-02-15       Impact factor: 11.025

7.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations.

Authors:  Fabio Marroni; Paolo Aretini; Emma D'Andrea; Maria Adelaide Caligo; Laura Cortesi; Alessandra Viel; Enrico Ricevuto; Marco Montagna; Giovanna Cipollini; Massimo Federico; Manuela Santarosa; Paolo Marchetti; Joan E Bailey-Wilson; Generoso Bevilacqua; Giovanni Parmigiani; Silvano Presciuttini
Journal:  Eur J Hum Genet       Date:  2004-11       Impact factor: 4.246

10.  Validation of family history data in cancer family registries.

Authors:  Argyrios Ziogas; Hoda Anton-Culver
Journal:  Am J Prev Med       Date:  2003-02       Impact factor: 5.043

View more
  12 in total

Review 1.  What characterizes cancer family history collection tools? A critical literature review.

Authors:  J E Cleophat; H Nabi; S Pelletier; K Bouchard; M Dorval
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

2.  The use of family history questionnaires: an examination of genetic risk estimates and genetic testing eligibility in the non-responder population.

Authors:  Susan Randall Armel; Kara Hitchman; Kathryn Millar; Laura Zahavich; Rochelle Demsky; Joan Murphy; Barry Rosen
Journal:  J Genet Couns       Date:  2011-03-30       Impact factor: 2.537

3.  Assessment of clinical practices among cancer genetic counselors.

Authors:  Deborah Wham; Thuy Vu; Gayun Chan-Smutko; Christine Kobelka; Diana Urbauer; Brandie Heald
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

4.  Cancer family history triage: a key step in the decision to offer screening and genetic testing.

Authors:  Paul Brennan; Oonagh Claber; Tracey Brennan
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

5.  All in the Family: Barriers and Motivators to the Use of Cancer Family History Questionnaires and the Impact on Attendance Rates.

Authors:  Susan Randall Armel; Jeanna McCuaig; Nicole Gojska; Rochelle Demsky; Manjula Maganti; Joan Murphy; Barry Rosen
Journal:  J Genet Couns       Date:  2015-01-07       Impact factor: 2.537

6.  Reading between the lines: a comparison of responders and non-responders to a family history questionnaire and implications for cancer genetic counselling.

Authors:  Julia H Appleby-Tagoe; William D Foulkes; Laura Palma
Journal:  J Genet Couns       Date:  2011-08-16       Impact factor: 2.537

7.  Breast and ovarian cancer: the forgotten paternal contribution.

Authors:  Jeanna M McCuaig; Celia M T Greenwood; Cheryl Shuman; David Chitayat; K Joan Murphy; Barry Rosen; Susan Randall Armel
Journal:  J Genet Couns       Date:  2011-04-19       Impact factor: 2.537

Review 8.  A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management.

Authors:  Kyla E Dunn; Colleen Caleshu; Allison L Cirino; Carolyn Y Ho; Euan A Ashley
Journal:  Circ Cardiovasc Genet       Date:  2013-02

9.  Literacy assessment of family health history tools for public health prevention.

Authors:  C Wang; R E Gallo; L Fleisher; S M Miller
Journal:  Public Health Genomics       Date:  2010-01-04       Impact factor: 2.000

10.  Using family history forms in pediatric oncology to identify patients for genetic assessment.

Authors:  A Hamilton; E Smith; J Hamon; E Tomiak; M Bassal; S L Sawyer
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.